Essity

Transaction in Own Shares • Jan 7, 2025

Press release

Stockholm, January 7, 2025

Buyback of Class B shares in Essity during week 1, 2025

Between December 30, 2024, and January 3, 2025, Essity Aktiebolag (publ) repurchased a total of 162,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on June 17, 2024. The buyback program will extend from June 17, 2024, until the 2025 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.

Date	Aggregated daily volume (no. of shares):	Weighted average price per day (SEK):	Total daily transaction value (SEK):
December 30, 2024	54,000	295.9333	15,980,398
January 2, 2025	54,000	295.9114	15,979,216
January 3, 2025	54,000	297.2804	16,053,142
Total accumulated during week 1 2025	162,000	296.3750	48,012,756
Total accumulated during the buyback program	7,506,000	300.5328	2,255,799,192

Class B shares in Essity were repurchased as follows:

All purchases were conducted on Nasdaq Stockholm by Danske Bank on behalf of Essity. Following the above purchases, Essity's holding of treasury shares amounted on January 7, 2025, to 7,506,000 Class B shares. The total number of shares in Essity amounted on the date of this press release to 702,342,489, of which 59,973,654 Class A shares and 642,368,835 Class B shares.

The full details concerning the completed transactions are appended to this press release.

For additional information, please contact:

Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

About Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2023, Essity had net sales of approximately SEK 147bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.